Gunter Van Hoof

Gunter Van Hoof is the Vice President of Global Clinical Trial Distribution at
Marken, UPS Healthcare Precision Logistics, where he leads worldwide operations for the
storage and distribution of temperature-sensitive investigational medicinal
products (IMPs) and advanced therapies. With over 25 years of experience in
the clinical trials industry, Gunter has developed deep expertise in global
supply chain management, cold-chain logistics, and operational excellence
for complex studies, including cell and gene therapies. He oversees Marken’s global depot network, ensuring compliance with GDP and GxP standards across all regions. Gunter is passionate about driving innovation in clinical trial distribution to support life-saving therapies and improve patient outcomes worldwide.

Gregory Jordan

Gregory Jordan is the Regional Vice President of Sales Engineering for international markets, where he works closely with customers to help them drive measurable business outcomes through more effective go‑to‑market execution. He leads teams that partner with buyers to align technology, insight, and enablement strategies to real commercial challenges.

Gregory brings a customer‑first approach to every engagement, focusing on how organizations can improve seller productivity, create more compelling buyer experiences, and accelerate decision‑making across complex sales cycles. He is known for helping customers simplify complexity—translating advanced capabilities into clear, executive‑level value that resonates with both business and technical stakeholders.

With deep experience supporting global organizations, Gregory is passionate about building trusted partnerships, sharing practical insight, and helping customers turn strategy into action at scale.

Christine Le

Christine Le is a highly respected financial planning professional with over 15 years of industry experience. She holds some of the profession’s most prestigious qualifications, including CFA Charterholder, Chartered Financial Planner (UK), Fellow of the Personal Finance Society (FPFS), and European Financial Planner™.

She is currently the Managing Director of Eastern Horizon Wealth Management, an Appointed Representative of St. James’s Place Wealth Management — one of the UK’s largest wealth management firms and a FTSE 100 company.

Christine holds a BSc in Economics from the University of Warwick, an MSc in Development Economics from the London School of Economics and Political Science (LSE), and an MBA in Finance from Cardiff University. She has further enhanced her expertise through a MicroMasters in Data Science at MIT and an executive programme in Fintech at the University of Oxford.

Her leadership and contribution to the profession have been widely recognised. Christine was named a Finalist at the 2024 Women in Financial Advice Awards and a Finalist at the 2025 FT Adviser Diversity in Finance Awards, hosted by the Financial Times.

Johnny Lancaster

Johnny Lancaster is General Manager of FSP at Parexel, where he leads the delivery of customized delivery solutions for clients across the clinical development spectrum. With over 20 years of experience in full-service and FSP models, Johnny has held leadership roles in strategic partnerships, global study start-up, and program management across multiple therapeutic areas. He specializes in designing flexible operating models tailored to each client’s unique needs, ensuring alignment with their strategic objectives while maintaining consistent, high-quality delivery. Johnny is passionate about leveraging innovative FSP approaches to help sponsors of all sizes accelerate their clinical programs and achieve their development goals

Dan Sommer

With more than two decades experience in the IT industry, Dan is a frequent industry speaker, blogger, and columnist on the topic of BI, analytics, and data integration. He is passionate about data literacy, supporting data-driven cultures, and tracking trends in the industry. Prior to joining Qlik, Dan was a Director of Research at Gartner.

Kenneth Wilson

Ken is a highly motivated and collaborative leader in the BioPharma industry with over three decades of experience in the CRO and sponsor sectors.  Proven track record of project management, line management, strategic planning, operational execution, business unit management and business development. Skilled in managing high-value partnerships with other sponsors and vendors, leading business growth, negotiating complex contracts and budgets, generating revenue increases in the CRO sector through innovative solutions and sourcing models, and delivering results across a broad range of clinical development programs and business models with key areas of expertise in: Strategic Partnership/Alliance Management, Management of Full-Service CROs, Ancillary Vendor and HCP Outsourcing and Contracting, End-to-End Project Management and Line Management.